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In the immune response to many antigens, it appears that bone marrow-derived (B) 
lymphocytes can only develop into antibody-forming cells (AFC)  1 in the presence of 
thymus-derived (T) lymphocytes (1). One suggested mechanism of this T-cell "help" 
is a focusing of antigen onto the B-cell surface (2). Recent in vitro studies have been 
interpreted as indicating that the critical factor in B-cell activation by both thymus- 
dependent and thymus-independent antigens is presentation of antigenic determinants 
in a multivalent configuration of suitable epitope density (3, 4). In the case of thymus- 
dependent antigens the role of the T cell is postulated to be the creation of the correct 
matrix of antigenic determinants on the macrophage surface (3). On the other hand, 
there have been proposals that B-cell activation may require two separate "signals" 
(5), "signal one" being union of antigen with the B-cell immunoglobulin receptor, and 
"signal two" being either a T-cell product (6-11) or a  factor released by the macro- 
phage (12-14). 
Recently I have described an in vitro situation in which B cells in the absence of T 
cells were able to be triggered by an antigen, freshly deaggregated fowl gamma globulin 
(F'yG), which clearly interacted with the B  cells while in a nonmultivalent form (13, 
15).  Such activation of the B  cell in the absence of T  cells required the presence of a 
second substance that for convenience can be termed a  signal-two source. Flagellin 
from Salmonella  strains, both in its polymerized and monomeric forms, and bacterial 
lipopolysaccharide (LPS)  all possessed signal-two activity in this system (16).  This 
system that used spleen cells from congenitally atbymic (nu/nu) mice (17) as a source 
of B cells seemed suitable for an assay of putative physiological sources of signal two, 
* This is publication no.  1898 from The Walter and Eliza Hall Institute of Medical Re- 
search, Parkville 3050, Victoria, Australia. 
1  Abbreviations used in this paper: AFC, antibody-forming cells; CFA, complete Freund's 
adjuvant; DRC, donkey erythrocytes; FCS, fetal calf serum;  F'yG, fowl gamma globulin; 
FLA, flagella; LPS, bacterial lipopolysaccharide;  2-ME, 2-~-mercaptoethanol;  PC, peritoneal 
cells; PEC,  peritoneal exudate cells;  POL,  polymerized flagellin;  PPB,  proteose peptone 
broth; S/N, supernatants; SRC, sheep erythrocytes. 
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as in the absence of the substances mentioned above there is absolutely no response to 
F3'G (13). 
The aim of the present  study was  to ask whether activated macrophages  or 
activated  T  cells functioned  as  sources  of  signal  two.  Supernatants  of mixed 
lymphocyte reactions have been claimed to replace T-cell function in a  primary 
in vitro response to heterologous erythrocytes (6, 7). However with this type of 
antigen  T  cell-deficient  systems  are  not  totally  unresponsive  (6,  7,  18),  and 
thus true restoration of T-cell function is difficult to distinguish from an amplifi- 
cation  of this  "thymus-independent"  residual  response.  Therefore  the present 
study uses an allogeneic interaction as a  source of nonspecific T  cell-dependent 
factors and compares the effects using (a)  F3'G as the antigen where there is no 
residual  response,  and  (b)  heterologous erythrocytes where a  small response in 
the absence of added factors is the rule. 
Materials and Methods 
Animals.--Congenitally athymic "nude" (nu/nu) mice from a closed but not inbred colony 
maintained by Dr. Margaret Holmes (19) were used between 6-8 wk of age. CBA/H/WEHI 
mice were used at 6-10 wk of age. 
Tissue Culture.--The method  of Marbrook as described elsewhere was used  (4).  Briefly 
15  >(  106 viable nucleated spleen cells plus antigens were cultured in 1 ml of  tissue culture 
fluid,  a  dialysis membrane separating  the cells from a  reservoir of 50 ml of medium.  The 
medium used was Eagle's minimal essential medium with nonessential amino acids  (Grand 
Island Biological Co., Grand Island, N. Y.) to which was added 5% fetal calf serum  (FCS) 
Commonwealth Serum Laboratories, Parkville, Melbourne, Australia). In some experiments, 
the medium was supplemented by 10  -5 M 2-/3-mercaptoethanol (2-ME). Cells were cultured 
for 3 or 4 days. 
Antigens.--Fowl gamma globulin (F'yG) and polymerized flagellin  (POL) or flagella (FLA) 
were prepared  as  described  elsewhere  (13).  Lipopolysaccharide  (LPS)  prepared  from Sal- 
monella typhimurium  was  obtained  from Difco Laboratories,  Inc.  (Detroit,  Mich.).  Sheep 
erythrocytes (SRC) were obtained from two sheep maintained at the Hall Institute.  Blood 
was stored in Alsever's solution at 4°C for 1-2 wk before use. SRC were washed three times in 
normal saline before addition to cultures. Donkey erythrocytes (DRC) were obtained from an 
animal maintained by Commonwealth Serum Laboratories and were stored at 4°C for 4 wk. 
Assays for A ntibody-Forming Cells (A FC).--Anti-FTG AFC were detected using a modified 
hemolytic plaque technique (13). Anti-SRC and anti-DRC AFC were detected using the ap- 
propriate erythrocytes in a modified hemolytic plaque assay (19). Results are expressed as the 
arithmetic means of groups of four cultures plus or minus the standard error of the mean. 
Production of Peritoneal Exudate Cells (PEC).--Mice, either CBA or nu/nu, were injected 
with 1 ml of sterile proteose peptone broth  (PPB)  (Difco Laboratories)  and 4-5 days later, 
peritoneal exudate cells were harvested in Dulbecco's solution. In certain experiments nu/nu 
mice were intraperitoneally injected with 0.1 ml of complete Freund's adjuvant (CFA) (Difco 
Laboratories). 
Preparation  of Peritoneal Cell (PC)  Supernatants  (S/N).--Normal  CBA or nu/nu  mice 
were used as the source of peritoneal ceils (PC) obtained by repeated washings of the peritoneal 
cavity with Dulbecco's solution. PC were washed once through an FCS underlayer. From 2 to 
10 X  106 PC were cultured for 16-24 h in small 35 x 10 mm plastic Petri dishes (1008; Falcon 
Plastics, Div. of BioQuest, Oxnard, Calif.). In some cases FCS was omitted from the washing 
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Mitomycin C Treatment of CBA Spleen Cells.--30  X  l0 G  CBA spleen cells were incubated 
for 30 rain at 37°C in medium containing 50 #g/ml mitomycin C  (Sigma Chemical Co., St. 
Louis, Mo.) after which the cells were washed through an FCS underlayer (20). 
Trypsin  Treatment of  Supernatants.--Crystalline  trypsin  (Grade  A;  Calbiochem  San 
Diego,  Calif.)  was added to supernatants to give a  final concentration of  100 #g/ml.  After 
incubation for 2 h at 37°C, trypsin inhibitor (from Soya bean type l-S; Sigma) was added  to 
100 #g/ml. Controls showed that trypsin plus inhibitor at the concentrations present in  cul- 
tures given trypsin-treated supernatants in this experiment do not inhibit antibody responses. 
RESULTS 
The Effect of the Addition  of nu/nu PEC on the Response of nu/nu Spleen to 
F'yG.--As a  step in investigating the possible role of  the activated macrophage 
in the triggering of the B  cell by a  thymus-dependent  antigen, peritoneal exudate 
cells  (PEC)  were  added  to  cultures  of  nu/nu  spleen  cells  together  with  an 
optimal dose of F'yG. Since the PEC  were obtained from nu/nu  mice, which are 
devoid of functional T  cells  (18),  no T  cells were being thus added  to the cul- 
tures.  Similarly no T  cell  function  could  have been involved  in activation of 
the PEC. 
Table  I  demonstrates  that  the  addition  of  PEC  from  nu/nu  mice  allowed 
TABLE  I 
PEC ftom Nude Mice Allow a Response to F'yG 
Added to cultures in addition to F~G  Anti-F~G AFC/culture 
--  0 
POL 10/zg  514  4-  66 
PEC 2.0 X  l0 G  362  4-  102 
"  0.25 X  106  214  4-  42 
--  0 
POL 10/zg  369  4-  50 
(a)  PEC 2 X  l0 G  204  4-  23 
"  106  138  4-  42 
"  105  72  4-  15 
"  104  18  4-  13 
(b)  PEC  l0 G  165  4-  40 
"  105  165  -4-  18 
"  104  24  4-  20 
Exp. I 
Exp. II 
Spleen ceils from nu/nu mice were cultured in the presence of 100/zg/ml F/G, plus either 
POL  or PEC,  from nu/nu mice injected 4  days earlier with 1 ml of PPB.  The PEC  were 
incubated for  11/~ h  with the F3'G before adding the spleen cells. The medium contained 
2-ME (10  -5 M). 4 days later the cells were harvested and assayed for anti-F'yG AFC. 
In one part, (a), of exp. II, nu/nu PEC were added in varying numbers to a mixture of the 
spleen cells and the antigen, while in the second part, (b), the PEC were incubated as in exp. 
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nu/nu spleen cells  to respond to F'yG. Clearly the factor allowing the B  cells 
to be activated by F'yG was not the product of T  cells and nor in this experi- 
mental design was it T  cell dependent. 
The Effect of Unstimulated Peritoneal Cells from Nude Mice.--When  normal, 
untreated nude mice were used as a source of peritoneal cells, as Table II shows, 
the responses were negligible.  Thus it seemed that the injection of PPB resulted 
in  either  migration  of  some new  cell  type into  the  peritoneal  cavity or  the 
activation of a  cell  type already present,  thereby allowing the peritoneal  cell 
population  to  act  as  a  source of  signal  two  for B-cell  activation.  That  the 
relevant cell type or a precursor was present in the unstimulated PC population 
was shown by subsequent experiments demonstrating that such PC could be 
stimulated in vitro to release a  substance with signal-two activity. 
The Activity of Complete  Freund's Adjuvant in Stimulating the Macrophage.-- 
TABLE II 
The Effect of Peritoneal Cells from nu/nu Mice Not Injected with PPB 
Added to cultures in addition to F,G  Anti-F~G AFC/culture 
6+6 
PC 106  12  4-  11 
105  6 4-  5 
104  0 
POL 10/zg  214 4-  53 
Spleen cells from nu/nu mice  were cultured with 100/zg/ml F3'G plus either peritoneal cells 
from unstimulated nu/nu mice or, as controls, POL 10 #g or nothing. Cells were harvested 
after 3 days. Similar results were obtained in experiments where the medium was  supple- 
mented with 2-ME (10  -5 M). 
Many adjuvants have stimulatory effects on the macrophage (e.g. 21, 22), but 
a  characteristic of T-deprived animals is that even with stimulation by com- 
plete  Freund's adjuvant  (CFA),  little  antibody may be  produced to T  cell- 
dependent  antigens.  Therefore it  was of interest  to  see  whether  CFA could 
activate peritoneal cells in nu/nu mice in the same manner as had been demon- 
strated for PPB. Table III shows that CFA in a  typical adjuvant dose was a 
poor inducer in peritoneal cells of the capacity to permit nu/nu spleen cells to 
respond to F3'G. The minimal effects  of peritoneal cells from normal animals 
seen in this experiment are of interest. These may reflect some natural activa- 
tion of peritoneal cells by infection. 
The Effect of Allogeneic PEC on the Response of nu/nu Spleen to F3'G.--The 
nu/nu mice used are not inbred and most cells in pools of nu/nu spleen cells 
will  exhibit  some  histocompatibility  products  (mostly  BALB/c  type)  that 
differ from those on CBA cells and some that are shared in common with CBA 
cells (18). Therefore CBA PEC were used to test whether some degree of histo- 1470  MECHANISM OF  ACTIVATION  OF  THE  B  LYMPHOCYTE 
TABLE III 
A  Comparison of PPB and CFA as Activators of nu/nu PC 
Added in adition to F~G  Anti-FvG AFC/culture 
--  0 
(a)  106 PEC (PPB stimulated)  256  4-  35 
10 a  "  "  87  4-  24 
(b)  106 PEC (CFA stimulated)  90  4- 36 
105  "  "  46  4-  26 
(c)  l0 s PC unstimulated  54  4-  42 
POL 10#g  381  4-  20 
Spleen cells from nu/nu mice were cultured  with F3~G 100 #g/ml plus PEC as indicated 
from nu/nu mice injected 4 days previously with either 1 ml of PPB (a), or 0.1 ml of CFA (b), 
or peritoneal ceils (PC) washed from normal nu/nu mice (c). Cells were harvested after 3 days. 
incompatibility was a barrier in this system. CBA PEC were cultured for 3 days 
after which period  the morphology of viable  cells was predominantly  that of 
active  macrophages.  Such  cell  populations  were  capable  of  allowing  nu/nu 
spleen cells to respond to F'/G (Table IV). 
The Effect of Supernatants  of Peritoneal Cells.--As a  first step in an analysis 
of the role of the macrophage in B-cell  triggering,  the  effect of supernatants 
from cultures of peritoneal  cells on the response of nu/nu spleen  cell cultures 
to F'yG was investigated. Table V  shows that peritoneal cells were releasing a 
factor into  the  culture  medium  that  facilitated  the  activation  of B  cells  by 
FTG. 
Stimulation  of PC by LPS.--Supernatants  of cultures of PC  that had con- 
tained 3/zg/ml of LPS were also active (Table V). Comparison of the effect on 
the response to F3'G by cultures of nu/nu spleen, of 0.5 ml of supernatant from 
CBA PC cultures containing LPS (1.5/zg) with the effect of 3/zg of LPS added 
directly  to  cultures,  shows  that  the  supernatant-treated  cultures  responded 
twice as well as those receiving LPS alone. Likewise 0.5 ml of supernatant  of 
cultures  of CBA PC  cultured  with  LPS  (LPS-S/N-CBA)  allowed a  response 
to F'yG, of about  twice  the magnitude  of that  developing in the  presence  of 
0.5 ml of supernatants  of CBA PC cultured in medium alone.  Since the  anti- 
F3'G AFC response  with  0.5  ml  of LPS-S/N-CBA,  at  a  mean  of 672  AFC/ 
culture, is of the order of the maximal seen with 100/zg of F3'G in the presence 
of optimal doses of POL or LPS (10 #g/ml), and since the effect of higher doses 
of these latter substances is to produce a plateau-level response to F~/G (13, 16), 
it was not possible to assume that a  simple addition of the effects of the LPS 
and  the  CBA-PC-supernatant  had  resulted  in  this  response.  In  fact  the  re- JOHN  W.  SCHRADER  1471 
TABLE  IV 
Allogeneic PEC Allow Triggering of nu/nu B Cells by FTG 
CBA PEC/culture  Anti-F~G AFC/culture 
--  0 
10  6  288  4-  72 
PEC from CBA mice were cultured for 3 days and added to cultures of nu/nu spleen cells 
together with 100/zg of F3'G. Control cultures contained 100 #g of F'yG alone. The medium 
contained 2-ME (10  -5 M) and the spleen cells were harvested after 3 days. 
TABLE V 
The Signal-Two Effect of Supernatants of Cultures of Peritoneal Cells 
Cultures contain 100/~g  F~G plus  Anti-F~G response 
AFC/culture 
POL 10 #g  618  -4-  180 
0.5 ml S/N-CBA  369  4-  54 
0.05 ml S/N-CBA  247  4-  78 
(b)  0.5 ml S/N-CBA (trypsinized)  90  4-  48 
3/zg LPS  316  4-  60 
(a)  0.5 ml LPS-S/N-CBA  672  4-  66 
(a)  0.05 ml LPS-S/N-CBA  513  4-  84 
(b)  0.5 ml LPS-S/N-CBA (trypsinized)  306  4-  60 
(c)  3/zg LPS (trypsinized)  445  4-  74 
(a)  0.5 ml LPS-S/N (nu/nu)  630  4-  48 
(a)  0.05 ml LPS-S/N (nu/nu)  342  4-  132 
Spleen cells from nu/nu mice were cultured with F'yG (100 #g/ird) plus supernatants  of 
overnight cultures of 10 X  106 PC from either CBA (S/N-CBA) or nu/nu (S/N-nu/nu) mice 
in 2 ml of medium containing 5% FCS. To some CBA PC cultures and all (nu/nu) PC cultures 
were added LPS (3/zg/ml), and nu/nu spleen cell cultures given 0.5 and 0.05 ml (a) of super- 
natants of these PC cultures contained a maximum of 1.5 and 0.15/zg of LPS, respectively. 
Trypsin treatment was performed as described in the Materials and  Methods section  and 
treated supernatants were added as indicated (b). As a control LPS, 3/zg, was also trypsinized 
and added to cultures (c). Cultures were harvested after 3 days. 
sponses of cultures to which 0.05 ml of LPS-S/N-CBA  had been added showed 
a  synergistic  effect  to  be  in  operation.  Here  the  amount  of  LPS  added  per 
culture  was  only  0.15  /zg,  an  amount  alone  allowing  a  barely  detectable  re- 
sponse  to  100  #g of F'yG  (16).  However the anti-F3,G  response  was  still at  a 
maximal level, which was twice that of cultures given 0.05 ml of S/N  from PC 
cultured without LPS. PC from nu/nu  mice also produced active supernatants, 1472  MECHANISM OF  ACTIVATION OF  THE  B  LYMPHOCYTE 
showing  that  the  production of  the  relevant factor was  T-cell independent 
(Table V). 
Treatment of PC Supernatants with Trypsin.--As a preliminary investigation 
of the chemical nature of the factor in PC supernatants with signal-two activity, 
the effect of treating PC supernatants with trypsin was investigated. Table V 
demonstrates that the activity of 0.5 ml of the supernatant of cultured CBA PC 
was reduced 75 %  by trypsin treatment.  Similarly the increase in activity of 
supernatants of PC cultured with LPS, over the activity of 3/~g of LPS alone, 
was abolished.  Control cultures where LPS was treated with trypsin demon- 
strated that the signal-two activity of LPS is unaffected by proteolytic enzymes. 
The  Effect  of Omitting  FCS in  Preparation  of PC  Supernatants.--Merely 
culturing PC seemed to be an adequate stimulus for the production of a factor 
allowing nu/nu spleen cells to respond to F~/G. Apart from the simple chemicals 
constituting the medium, the possible stimuli were the plastic dish or the FCS. 
Therefore the effect of omitting the FCS from the medium in which PC were 
cultured was investigated. Table VI shows that FCS appeared to be a stimula- 
tory influence on  the  production by  cultured  PC  of  supernatants  allowing 
nu/nu spleens to respond to FTG. 
The Effect  of Addition  of Allogeneic Spleen  Cells to the Response  of nu/nu 
Spleen to F~/G.--Allogeneic interactions have been shown to  circumvent the 
requirement for the presence of specific T  cells in in vivo secondary responses 
(23) and primary responses to one antigen with special properties, DNP-D-GL 
(DNP  conjugate  of  a  synthetic  random  copolymer of D-glutamic  acid  and 
D-lysine)  (24). In in vitro studies Schimpl and Wecker have shown that a factor 
released from allogeneically stimulated T  cells can reconstitute the response of 
T  cell-deficient spleen cell cultures to SRC  (7). An allogeneic interaction be- 
tween CBA spleen cells and spleen cells from the noninbred nu/nu mice (25) 
was used as the basis of the following experiments (Table VII) that were de- 
signed  to  examine the  effect of T  cell-dependent factors on antigen-induced 
TABLE  VI 
The  Effect  of FCS in  Stimulating  PC 
Supernatant from  Anti-F~G AFC/culture 
nu/nu PEC +  5% FCS  193  4-  54 
nu/nu PEC (no FCS)  54  ~  33 
(~)  --  o 
Normal nu/nu mice were the source of peritoneal cells that were cultured (2.10 ~) in small 
plastic Petri dishes for 20 h in either 2 ml of normal tissue culture medium with 5% FCS or 
2 ml of medium without FCS. To each culture of nu/nu spleen cells was added FTG (100/zg) 
plus 0.25 ml of supernatants of the PC obtained with or without FCS being present. A control 
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TABLE  VII 
The Requirement  for the Presence of FLA in the Enhancing Effect of Allogendc 
Spleen Cells on the Response of B Cells to F'yG 
FLA  CBA spleen cells  Anti-F~G AFC/culture 
--  --  0 
+  --  163  4-  60 
+  104  198  4-  35 
+  10 ~  286  4-  114 
+  106  913  4-  150 
106  0 
Spleen cells from nu/nu mice were cultured with 100/~g of Fh'G plus graded numbers of 
allogeneic CBA spleen cells from normal mice as indicated. Flagella (FLA) were present 
(10 #g/ml) as indicated. Cultures were harvested after 4 days. 
triggering in this system. The addition  of small numbers of CBA spleen cells 
to cultures of nu/nu spleen containing F3'G 100 #g/ml did not reverse the in- 
ability of nu/nu  spleen cells to respond to  F3'G. However a  clear enhancing 
effect on  the  anti-F3'G response was seen when  increasing  numbers of CBA 
spleen cells were added to cultures containing, in addition to F3'G, a substance 
having  signal-two  activity,  such  as  POL  or  FLA  (13).  Thus  the  conclusion 
seemed clear that the addition of CBA spleen cells had an effect on only B cells 
that had been already activated by F'rG plus signal two. Alone, an allogeneic 
interaction, despite its profound amplifying effect on the AFC response eventu- 
ating from F'yG-reactive B  cells that had been already activated, had no in- 
fluence as a second signal in the triggering event. 
The Effect of Mitomycin C Treatment of the CBA Spleen Cells.--There is evi- 
dence (reviewed by Miller [1]) that unimmunized T  cells must undergo division 
before being effective as helper cells.  Therefore CBA cells were preincubated 
with  a  dose  of mitomycin  C  shown  to  be sufficient  to  totally  inhibit  [3H]- 
thymidine uptake in cultures of spleen cells (20)  in order to exclude the pos- 
sibility that specific helper T  cells had been activated in the presence of POL. 
Table VIII shows  that  mitomycin C-treated  CBA  spleen  cells  were just  as 
effective as untreated  CBA spleen, indicating that proliferation of the T  cells 
was not required for the allogeneic effect. 
The Synergistic Effect of Allogeneic Spleen Cells Plus PC Supernatants on the 
Response  to  F'yG  of nu/nu  Spleen.--To  test  the  hypothesis  that  a  factor in 
supernatants from cultured PC was providing a  substance important in B-cell 
triggering,  while allogeneic interactions  were releasing factors amplifying the 
effects of B-cell triggering in terms of numbers of resultant AFC, the effect on 
the response to  F~/G of adding  such  PC  supernatants  plus  allogeneic spleen 
cells to cultures of nu/nu  spleen was examined.  Fig.  1 depicts  the results of 1474  MECHANISM  OF  ACTIVATION  OF  THE  B  LYMPHOCYTE 
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FIG. 1.  Synergism between supernatants  of PC and an allogeneic interaction  in the anti- 
F'yG response of nu/nu spleen. Groups of four cultures of nu/nu spleen were set up each with 
100 ~zg/ml F3'G plus additional factors as indicated. The dose of S/N was 0.5 ml of an over- 
night culture of PC. In one group this was treated with trypsin (as in Materials and Methods), 
before addition to the cultures. The allogeneic interaction was provided by 106 mitomycln C- 
treated CBA spleen ceils added to each culture. 
such an experiment.  Clearly in the presence of such supernatants,  nu/nu  cul- 
tures given allogeneic CBA spleen cells were able to respond to F'yG. It was also 
evident that responses in the presence of CBA cells plus supernatant and F'yG 
were higher than those of cultures with supernatant and Fq~G alone. Thus the 
same  synergism was  apparent  between  the  allogeneic  effect and  macrophage 
supernatants,  as had been found between the allogeneic effect and POL (Table 
vii). This particular experiment also showed again that trypsin diminished the 
stimulatory activity of macrophage supernatants. 
The Effect of POL and Allogeneic-Recognition Factor on Responses of nu/nu 
Spleen to Heterologous Erythrocytes.--For  the purposes of comparison with the 
data obtained with F'yG, the effect of these two influences on the in vitro re- 
sponse of nu/nu mice  to a  second class of thymus-dependent  antigens, heter- 
ologous erythrocytes (1), was examined. Table IX shows the results of experi- 
ments with DRC and SRC. In contrast to the F~G system, there is a  definite 
response of the T  cell-deficient nu/nu  spleen  cells  to both SRC and DRC in 
the  absence  of the  addition  of any second substance.  Addition  of POE  does J'OHN  W.  SCHRADER  1475 
TABLE  VIII 
The Undiminished Activity of Mitomycin  C-Treated Allogeneic Spleen Cells in 
Amplifying the Response of B Cells to F'yG in the Presence of POL 
POL  CBA spleen cells (106/culture)  Anti-F~G AFC/culture 
--  --  0 
+  --  204  4-  42 
-1-  Normal  1,218  4-  198 
+  Mitomycin C  treated  1,470  -4-  264 
m 
Normal  0 
Mitomycin C  treated  0 
Spleen cells from nu/nu mice were cultured with FyG 100 #g/ml. CBA spleen cells, either 
treated  with mitomycin C  as described above  or left untreated,  were added to cultures as 
indicated. POL (10 #g/ml) was present as indicated. Cultures were harvested after 4 days. 
TABLE  IX 
Enhancing Effect of both Allogeneic Spleen Cells Alone and POL on the Response 
of nu/nu Spleen Cells to Heterologous Erythrocytes 
Added to cultures  Anti-DRC AFC/culture  Anti-SRC AFC/culture 
--  190  4-  100  209  ±  88 
10 #g POL  952  ±  343  1,958  ±  440 
106  CBA spleen cells  1,402  ±  473  2,959  ±  924 
Spleen cells from nude mice were cultured with 3.106 DRC and 3.106 SRC. To some groups 
were added 10 #g of POL, to others  106 CBA spleen cells, treated with mitomycin C  as de- 
scribed above. 
produce in both systems a large increase in numbers of AFC. However in con- 
trast  to  the situation with  FTG,  the  addition of allogeneic CBA  cells alone 
without any POL being present markedly raised the numbers of AFC produced. 
DISCUSSION 
Spleen cells from nu/nu mice cannot respond in tissue culture to the antigen 
F3'G by AFC production unless a source of some substance aiding in the trigger- 
ing event (a signal-two substance) is added (13,  15, 16). This study has shown 
that activated peritoneal cells, but not freshly harvested, unactivated peritoneal 
cells,  allow  cultured nu/nu  spleen  cells  to  respond  to  F3'G.  Since the  PEC 
population that was active after preliminary culture (Table IV) consisted almost 
entirely of active macrophages,  these are most likely to be the relevant cell 
type. Supernatants of cultured peritoneal cells were able to substitute for PEC 
and the activity of these supernatants was sensitive to trypsin, suggesting that 
the active factor is a protein. Because the peritoneal cell populations could be 
obtained from nu/nu mice, it can be concluded that the activation of macro- 1476  MECHANISM  OF  ACTIVATION OF  THE  B  LYMPHOCYTE 
phages to  release such a  factor does not require  T  cells,  at least under the 
present experimental circumstances. 
The stimulatory action of PPB on PC in vivo may well reflect some content 
of endotoxin, a well-established macrophage stimulant (26 and Table V). The 
minimal sfimulatory action of PC in vivo of CFA is somewhat unexpected but 
quite consistent with its ineffectiveness in contrast to POL as an adjuvant for 
the anti-FqcG response of nu/nu mice in vivo (unpublished data). The increased 
release of signal-two material from cultured PC in the presence of FCS was of 
interest. This probably represents a true stimulation of macrophages, as other 
studies have shown that FCS raises levels of cathepsin D and acid phosphatase 
in cultured peritoneal cells (27). 
Recently it has been proposed that the second signal for B-cell activation is 
provided by the interaction of the complement component C3b with the B-cell 
surface (14).  It is possible that LPS and POL and even monomeric flagellin 
(16)  are  acting via  C3  activation in  this  system. Likewise the  supernatant 
factor could be a  C3-splitting protease, although as yet there is no pertinent 
evidence. Conversely it is conceivable that the role of C3 activation in the im- 
mune response could be in the activation of the macrophage to secrete a signal- 
two substance. 
The second part of this study showed that the addition of living allogeneic 
T  cells to cultures of nu/nu spleen with F~cG could not by itself facilitate the 
generation of anti-F'/G AFC. In contrast if such a source of allogeneic factors 
(6, 7, 25) was added to cultures containing POL or macrophage supernatants 
in addition to F~,G,  a  greatly augmented production of anti-F~/G AFC was 
seen. These experiments therefore differentiate two forms of stimulatory activity 
in this in vitro system namely, (a) a second-signal factor produced by activated 
macrophages  that  allows  an  antigen-B-cell  interaction to  proceed  to  B-cell 
activation and  (b)  a T  cell-dependent amplifying factor that is produced by 
allogeneic interaction, and which while not itself involved in B-cell triggering, 
does amplify the number of AFC produced (25, 27-29)  perhaps by a mitogenic 
effect (30). 
The present  study confirms previous reports  (6,  7)  that allogeneic effects 
"restore" the responses of T cell-deficient cultures to heterologous erythrocytes. 
However, in contrast to the case with F'yG, nu/nu spleen cells challenged with 
heterologous erythrocytes alone do give a  small but definite response  (Table 
IX). Thus the restoration by allogeneic factors may be explained by an ampli- 
fication of this basal thymus-independent response without any influence on 
B-cell activation. 
Why are heterologous erythrocytes able to trigger a significant AFC response 
in nu/nu spleen  cells without addition of any signal-two source? Of several 
possibilities that suggest themselves two seem especially worthy of exploration. 
Firstly, such responses may involve a  different subpopulation of "memory" 
B  cells  with  prior  experience  of  cross-reacting  antigens  (31) and  thus  be JOHN  W.  SCHRADER  1477 
triggered according to different rules.  Secondly, particulate antigens such as 
erythrocytes could during the process of phagocytosis activate the macrophage 
to release a  signal-two substance. The small response to erythrocyte antigens 
in T  cell-deficient mice (e.g.  18, 32) stands in contrast to the response to more 
conventional thymus-independent antigens. A probable reason is that the latter 
in general are bacterial products or artificial substances  (33) that persist for 
prolonged periods in the body due to their nondegradability. It is suggested 
that these substances are able to provide signal two for B-cell activation, either 
by direct interaction with the B cell or by activating the macrophage, a function 
perhaps facilitated by their nondegradability. 
The present study has shown that B-cell triggering, resulting at least in an 
IgM response to a  thymus-dependent antigen, need not involve the T  cell. It 
suggests that the activated T  cell has a  nonspecific amplifying influence on 
B-cell responses, but that this affects only those B cells that have been activated 
by a separate mechanism. The data are compatible with the hypothesis that the 
B  cell is triggered at the macrophage surface where it encounters (a)  antigen 
and (b) a short-ranged second-signal substance secreted by the macrophage. It 
is worth noting that the T  cell may also be activated by antigen presented by 
the macrophage (reviewed in 34, 35) perhaps with the involvement of a soluble 
factor (36, 37). 
How can demonstrations of carrier  specificity be  explained? Firstly there 
could be  a  requirement in vivo for the anatomical proximity of the B  cell, 
macrophage, and T  cell. Secondly the T  cell may have an active role in actual 
B-cell triggering through a focusing of antigen onto the macrophage surface (3). 
The above hypothesis predicts that antibody responses resulting from the 
activation of the B cell in the absence of T cells will be deficient, because of the 
lack of the proliferative influence of the activated T  cell. Also relevant is the 
role of the T cell in determining antibody affinity and class (1). Thus the results 
of Unanue (38), where antigen presented to thymectomized mice on activated 
macrophages did not alter the serum antigen-binding capacity, do not neces- 
sarily contradict the present study since in his study a  small transient IgM 
response may not have been detected. 
SUMMARY 
Peritoneal exudate cells from nu/nu mice stimulated with proteose peptone 
broth, but in general not from unstimulated mice, permitted cultures of spleen 
cells  from  congenitally athymic  (nu/nu)  mice  to  respond  to  the  thymus- 
dependent antigen fowl gamma globulin (F~G).  Supernatants of cultures of 
peritoneal cells were also effective, the activity being sensitive to trypsin. Since 
nu/nu mice were effective sources of the peritoneal cells  it would not seem 
obligatory for the thymus-derived (T) cell to be involved in the triggering of 
the bone marrow-derived (B) cell by a  thymus-dependent antigen F~/G. It is 
proposed that the B  cell is triggered at the macrophage surface where it en- 1478  MECHANISM  OF  ACTIVATION  OF  THE  B  LYMPHOCYTE 
counters two signals (a) the antigen and (b) a protein secreted by the activated 
macrophage. In vivo the T  cell may have a  role in B-cell triggering,  either in 
activating the macrophage or in aiding in presentation of antigen on the macro- 
phage surface.  Thymus-independent  antigens  are proposed to induce an IgM 
response because they are able to provide "signal two" either by direct inter- 
action with  the B  cell or via irritation  or activation of the macrophage. The 
stimulatory effect of T  cells activated by an allogeneic interaction was used as a 
model of one influence of the T  cell on the development of an antibody response. 
The presence in cultures  of nu/nu spleen  of an allogeneic interaction  had no 
effect on the inability of these cells to respond to F3,G. However when a source 
of the postulated second signal such as the supernatant of a macrophage culture 
was present,  an allogeneic interaction had a  powerful amplifying effect on the 
anti-F~G response. In contrast the response of nu/nu spleen cultures to heter- 
ologous erythrocytes  was  greatly  enhanced  by  the  presence  of an  allogeneic 
interaction. It is suggested that since there was a definite basal response to the 
heterologous  erythrocytes  added  alone,  the  enhancement  represented  not  an 
activation of more B  cells but  rather  an amplification of this  basal  response. 
Thus the anti-F~tG response in cultures of nu/nu spleen differentiates between 
factors such as those released  by activated macrophages that are involved in 
B-cell  triggering  and  factors  released  by  activated  T  cells  that  amplify  the 
numbers of antibody-forming cells resulting from a  B  cell already triggered. 
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